Integrating Chinese and Western medicines reduced the incidence of hepatocellular carcinoma in patients with diabetes mellitus: A Taiwanese population-based cohort study.
CONCLUSION: This nationwide retrospective cohort study from Taiwan provides some valuable insights into the prescribing characteristics of CHM treatment in patients with DM. Compared with use of Western antidiabetic medications alone, use of adjuvant CHM effectively reduces the incidence of HCC in patients with DM.
PMID: 32147062 [PubMed - in process]
Source: Complementary Therapies in Medicine - Category: Complementary Medicine Authors: Lu HL, Su YC, Lin MC, Sun MF, Huang ST Tags: Complement Ther Med Source Type: research
More News: Alternative and Complementary Therapies | Cancer | Cancer & Oncology | Carcinoma | China Health | Complementary Medicine | Databases & Libraries | Diabetes | Diabetes Mellitus | Endocrinology | Epidemiology | Health Insurance | Hepatocellular Carcinoma | Herbs | Insurance | Liver | Liver Cancer | Study | Taiwan Health | Urology & Nephrology